Non-invasive Pulse Wave Tonometer Market

Non-invasive Pulse Wave Tonometer Market Snapshot (2022 to 2032)

The global non-invasive pulse wave tonometer market size is expected to be valued at USD 104.3 Million in 2022. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around USD 194 Million by 2032.

Blood flow in the body should be proper to maintain health and also reduce the risk of heart and other problems associated with blood flow. As the blood flow starts its journey from the heart and flows through various veins and arteries. Blood is a very good carrier that can carry nutrients and drugs to different parts of the body.

Data Points	Key Statistics
Non-invasive Pulse Wave Tonometer Market Value 2022	USD 104.3 Million
Non-invasive Pulse Wave Tonometer Market Projected Value (2032)	USD 194 Million
Non-invasive Pulse Wave Tonometer Market CAGR (2022 to 2032)	5.8%

The non-invasive pulse wave tonometer is a very good device that can help to understand the flow pattern and provide the information so that the proper treatment can be provided.

Non-invasive Pulse Wave Tonometer Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)

From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 4.7%. The proper monitoring of blood flow helps to manage the flow of blood and also help the doctors and another healthcare professional to monitor the patients for various disorders such as COPD (Chronic Obstructive Pulmonary Disease), hypertension, and other problem, non-invasive pulse wave tonometer is used mainly consider for the heart-related problem. Nowadays most treatment centers are using these devices.

Non-invasive pulse wave tonometer is mostly used for monitoring blood flow and understanding the various diseases, to provide treatment. Various innovations are going on for developing the product to provide real-time monitoring of flow and provide treatment. The increasing number of patients and technological enhancement is the major potential for the non-invasive pulse wave tonometer market. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around USD 194 Million by 2032.

Which Drivers Underpin Non-invasive Pulse Wave Tonometer Industry Expansion?

Increased Product Innovation Likely to Augment Non-invasive Pulse Wave Tonometer Sales

Non-invasive pulse wave tonometer is a growing market over the forecast period, as the number of patients is increasing related to heart, hypertension, and others. According to the British Lung Foundation, approx. 1.2 million people are suffering from COPD. The number of patients who are suffering from heart-related problems is also increasing in every region of the world.

The players are also coming up with new product innovations to make the product portable and provide in-depth monitoring of blood flow. The major strength of the system is that it can monitor the flow of blood non-invasive, while in the traditional case, the catheter was inserted to monitor the flow.

Which Factors are limiting the Growth of the Non-invasive Pulse Wave Tonometer Market?

High Rates of Investment to Impede the Growth

Although Non-invasive Pulse Wave Tonometer offers good ROI in the long run, the high initial investment is a deterrent for many organizations.

The high cost along with awareness and viability of the product the hinderers of the non-invasive pulse wave tonometer market.

Region-wise Insights

Will North America Continue Dominance in the Global Non-invasive Pulse Wave Tonometer Market?

Rising Market Competition to Boost the Market Growth in North America

The North American non-invasive pulse wave tonometer market is expected to accumulate a market share of 33.7% in 2022. North America is dominating and contributing the leading shares to the non-invasive pulse wave tonometer market in terms of revenue and is expected to register significant growth over a forecast period due to the increasing market competition.

The rising prevalence of glaucoma in the region is also adding to the market growth. According to the American Academy of Ophthalmology (AAO), glaucoma affects over 2.7 million of the population aged 40 and older in the USA

How big is the Non-invasive Pulse Wave Tonometer Market in Europe?

Rising Prevalence of Glaucoma Risk Factors to Boost Market Growth in Europe

The European region is anticipated to hold a market share of 30.8%. According to the WHO, there are over 60 million people living with diabetes in the European region. This is mainly due to rising behavioral risk factors such as smoking, alcohol consumption, unhealthy food habits, and a sedentary lifestyle.

Europe is expected to contribute to moderate revenue market share and register a healthy growth rate in the global Non-invasive Pulse Wave Tonometer market due to the rising prevalence of glaucoma risk factors such as diabetes, myopia, and hypertension in the region.

Start-ups for Non-invasive Pulse Wave Tonometer Market

Some key start-ups in the Non-invasive Pulse Wave Tonometer market include:

• Tucson medical start-up CATS Tonometer won federal clearance to market a disposable version of its device to measure internal eye pressure, with plans to start selling the instrument this fall. The USA Food and Drug Administration approved CATS Tonometer’s disposable version of a prism device that increases the accuracy of a common instrument that measures eye pressure to diagnose diseases such as glaucoma. The company, founded in 2015 by the University of Arizona alumni Dr. Sean McCafferty, won FDA clearance for a reusable version of its patented prism in 2018. Market clearance is a form of FDA market approval mainly based on a medical device’s similarity to an already-approved device
• iCare HOME2 provides unsurpassed ease of use and accuracy in monitoring real-world intraocular pressure behavior outside of the doctor’s office and clinical hours, supporting glaucoma management. Glaucoma is a chronic, progressive disease of the optic nerve. As intraocular pressure (IOP) is the only modifiable risk factor for glaucoma progression, disease management is centered on reducing IOP. Most patients can utilize iCare HOME2 simply by following the advice and guidance in the instruction materials, freeing up healthcare professionals’ precious time. iCare HOME2’s smart light guide helps the patient position the device correctly and make the measurements effortlessly and accurately, every time.

Who are the Leading Players in the Non-invasive Pulse Wave Tonometer Market?

Prominent players in the Non-invasive Pulse Wave Tonometer market are ADInstruments, Millar, DiaTecne s.r.l. and AtCor Medical Pty Ltd., and various other regional players.

• In March 2021, iCare launched a digitally-driven tonometer, iCare Home 2, for patient home use, which has a fully integrated app for IOS and android and utilizes the cloud for data security and storage. It allows patients to self-measure their IOP (intraocular pressure) without the need to come to a clinic or hospital.
• In February 2021, Reichert Technologies, a business unit of AMETEK Inc., launched Tono-Vera Vet Tonometer with ActiView Positioning System. It utilizes rebound tonometer technology, which eliminates the need for a topical anesthetic.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 5.8% from 2022 to 2032
Market Value in 2022	USD 104.3 Million
Market Value in 2032	USD 194 Million
Base Year for Estimation	2021
Historical Data	2016 to 2021
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	End-User, Indication, Region
Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA)
Key Countries Profiled	The USA, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, India, Malaysia, Singapore, Thailand, China, Japan, South Korea, Australia, New Zealand, GCC, South Africa, Israel
Key Companies Profiled	ADInstruments; Millar; DiaTecne s.r.l; AtCor Medical Pty. Ltd.; Haag Streit AG; Ametek Industries Technology; Ray Vision International Corporation; Crystalvue Medical; Shanghai Vowish Optical Co. Ltd.
Customization	Available upon Request

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Analysis 2016 to 2021 and Forecast, 2022 to 2032
• 5. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Indication
  • 5.1. Hypertension
  • 5.2. Renal Disease
  • 5.3. COPD
  • 5.4. Diabetes
  • 5.5. Heart Failure
  • 5.6. Others
• 6. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
  • 6.1. Hospitals
  • 6.2. Clinics
  • 6.3. Others
• 7. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
  • 7.1. North America
  • 7.2. Latin America
  • 7.3. Europe
  • 7.4. South Asia
  • 7.5. East Asia
  • 7.6. Oceania
  • 7.7. MEA
• 8. North America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 9. Latin America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 10. Europe Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 11. South Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 12. East Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 13. Oceania Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 14. MEA Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
• 15. Key Countries Analysis
• 16. Market Structure Analysis
• 17. Competition Analysis
  • 17.1. ADInstruments
  • 17.2. Millar
  • 17.3. DiaTecne s.r.l.
  • 17.4. AtCor Medical Pty Ltd.
  • 17.5. Haag Streit AG
  • 17.6. Ametek Industries Technology
  • 17.7. Ray Vision International Corporation
  • 17.8. Crystalvue Medical
  • 17.9. Shanghai Vowish Optical Co., Ltd.
• 18. Assumptions & Acronyms Used
• 19. Research Methodology

List of Tables

Table 1: Global Value (US$ million) Forecast by Region, 2016 to 2032

Table 2: Global Value (US$ million) Forecast by Indication, 2016 to 2032

Table 3: Global Value (US$ million) Forecast by End User, 2016 to 2032

Table 4: North America Value (US$ million) Forecast by Country, 2016 to 2032

Table 5: North America Value (US$ million) Forecast by Indication, 2016 to 2032

Table 6: North America Value (US$ million) Forecast by End User, 2016 to 2032

Table 7: Latin America Value (US$ million) Forecast by Country, 2016 to 2032

Table 8: Latin America Value (US$ million) Forecast by Indication, 2016 to 2032

Table 9: Latin America Value (US$ million) Forecast by End User, 2016 to 2032

Table 10: Europe Value (US$ million) Forecast by Country, 2016 to 2032

Table 11: Europe Value (US$ million) Forecast by Indication, 2016 to 2032

Table 12: Europe Value (US$ million) Forecast by End User, 2016 to 2032

Table 13: South Asia Value (US$ million) Forecast by Country, 2016 to 2032

Table 14: South Asia Value (US$ million) Forecast by Indication, 2016 to 2032

Table 15: South Asia Value (US$ million) Forecast by End User, 2016 to 2032

Table 16: East Asia Value (US$ million) Forecast by Country, 2016 to 2032

Table 17: East Asia Value (US$ million) Forecast by Indication, 2016 to 2032

Table 18: East Asia Value (US$ million) Forecast by End User, 2016 to 2032

Table 19: Oceania Value (US$ million) Forecast by Country, 2016 to 2032

Table 20: Oceania Value (US$ million) Forecast by Indication, 2016 to 2032

Table 21: Oceania Value (US$ million) Forecast by End User, 2016 to 2032

Table 22: MEA Value (US$ million) Forecast by Country, 2016 to 2032

Table 23: MEA Value (US$ million) Forecast by Indication, 2016 to 2032

Table 24: MEA Value (US$ million) Forecast by End User, 2016 to 2032

List of Figures

Figure 1: Global Value (US$ million) by Indication, 2022 to 2032

Figure 2: Global Value (US$ million) by End User, 2022 to 2032

Figure 3: Global Value (US$ million) by Region, 2022 to 2032

Figure 4: Global Value (US$ million) Analysis by Region, 2016 to 2032

Figure 5: Global Value Share (%) and BPS Analysis by Region, 2022 to 2032

Figure 6: Global Y-o-Y Growth (%) Projections by Region, 2022 to 2032

Figure 7: Global Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 8: Global Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 9: Global Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 10: Global Value (US$ million) Analysis by End User, 2016 to 2032

Figure 11: Global Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 12: Global Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 13: Global Attractiveness by Indication, 2022 to 2032

Figure 14: Global Attractiveness by End User, 2022 to 2032

Figure 15: Global Attractiveness by Region, 2022 to 2032

Figure 16: North America Value (US$ million) by Indication, 2022 to 2032

Figure 17: North America Value (US$ million) by End User, 2022 to 2032

Figure 18: North America Value (US$ million) by Country, 2022 to 2032

Figure 19: North America Value (US$ million) Analysis by Country, 2016 to 2032

Figure 20: North America Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 21: North America Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 22: North America Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 23: North America Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 24: North America Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 25: North America Value (US$ million) Analysis by End User, 2016 to 2032

Figure 26: North America Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 27: North America Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 28: North America Attractiveness by Indication, 2022 to 2032

Figure 29: North America Attractiveness by End User, 2022 to 2032

Figure 30: North America Attractiveness by Country, 2022 to 2032

Figure 31: Latin America Value (US$ million) by Indication, 2022 to 2032

Figure 32: Latin America Value (US$ million) by End User, 2022 to 2032

Figure 33: Latin America Value (US$ million) by Country, 2022 to 2032

Figure 34: Latin America Value (US$ million) Analysis by Country, 2016 to 2032

Figure 35: Latin America Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 36: Latin America Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 37: Latin America Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 38: Latin America Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 39: Latin America Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 40: Latin America Value (US$ million) Analysis by End User, 2016 to 2032

Figure 41: Latin America Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 42: Latin America Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 43: Latin America Attractiveness by Indication, 2022 to 2032

Figure 44: Latin America Attractiveness by End User, 2022 to 2032

Figure 45: Latin America Attractiveness by Country, 2022 to 2032

Figure 46: Europe Value (US$ million) by Indication, 2022 to 2032

Figure 47: Europe Value (US$ million) by End User, 2022 to 2032

Figure 48: Europe Value (US$ million) by Country, 2022 to 2032

Figure 49: Europe Value (US$ million) Analysis by Country, 2016 to 2032

Figure 50: Europe Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 51: Europe Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 52: Europe Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 53: Europe Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 54: Europe Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 55: Europe Value (US$ million) Analysis by End User, 2016 to 2032

Figure 56: Europe Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 57: Europe Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 58: Europe Attractiveness by Indication, 2022 to 2032

Figure 59: Europe Attractiveness by End User, 2022 to 2032

Figure 60: Europe Attractiveness by Country, 2022 to 2032

Figure 61: South Asia Value (US$ million) by Indication, 2022 to 2032

Figure 62: South Asia Value (US$ million) by End User, 2022 to 2032

Figure 63: South Asia Value (US$ million) by Country, 2022 to 2032

Figure 64: South Asia Value (US$ million) Analysis by Country, 2016 to 2032

Figure 65: South Asia Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 66: South Asia Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 67: South Asia Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 68: South Asia Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 69: South Asia Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 70: South Asia Value (US$ million) Analysis by End User, 2016 to 2032

Figure 71: South Asia Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 72: South Asia Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 73: South Asia Attractiveness by Indication, 2022 to 2032

Figure 74: South Asia Attractiveness by End User, 2022 to 2032

Figure 75: South Asia Attractiveness by Country, 2022 to 2032

Figure 76: East Asia Value (US$ million) by Indication, 2022 to 2032

Figure 77: East Asia Value (US$ million) by End User, 2022 to 2032

Figure 78: East Asia Value (US$ million) by Country, 2022 to 2032

Figure 79: East Asia Value (US$ million) Analysis by Country, 2016 to 2032

Figure 80: East Asia Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 81: East Asia Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 82: East Asia Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 83: East Asia Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 84: East Asia Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 85: East Asia Value (US$ million) Analysis by End User, 2016 to 2032

Figure 86: East Asia Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 87: East Asia Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 88: East Asia Attractiveness by Indication, 2022 to 2032

Figure 89: East Asia Attractiveness by End User, 2022 to 2032

Figure 90: East Asia Attractiveness by Country, 2022 to 2032

Figure 91: Oceania Value (US$ million) by Indication, 2022 to 2032

Figure 92: Oceania Value (US$ million) by End User, 2022 to 2032

Figure 93: Oceania Value (US$ million) by Country, 2022 to 2032

Figure 94: Oceania Value (US$ million) Analysis by Country, 2016 to 2032

Figure 95: Oceania Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 96: Oceania Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 97: Oceania Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 98: Oceania Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 99: Oceania Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 100: Oceania Value (US$ million) Analysis by End User, 2016 to 2032

Figure 101: Oceania Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 102: Oceania Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 103: Oceania Attractiveness by Indication, 2022 to 2032

Figure 104: Oceania Attractiveness by End User, 2022 to 2032

Figure 105: Oceania Attractiveness by Country, 2022 to 2032

Figure 106: MEA Value (US$ million) by Indication, 2022 to 2032

Figure 107: MEA Value (US$ million) by End User, 2022 to 2032

Figure 108: MEA Value (US$ million) by Country, 2022 to 2032

Figure 109: MEA Value (US$ million) Analysis by Country, 2016 to 2032

Figure 110: MEA Value Share (%) and BPS Analysis by Country, 2022 to 2032

Figure 111: MEA Y-o-Y Growth (%) Projections by Country, 2022 to 2032

Figure 112: MEA Value (US$ million) Analysis by Indication, 2016 to 2032

Figure 113: MEA Value Share (%) and BPS Analysis by Indication, 2022 to 2032

Figure 114: MEA Y-o-Y Growth (%) Projections by Indication, 2022 to 2032

Figure 115: MEA Value (US$ million) Analysis by End User, 2016 to 2032

Figure 116: MEA Value Share (%) and BPS Analysis by End User, 2022 to 2032

Figure 117: MEA Y-o-Y Growth (%) Projections by End User, 2022 to 2032

Figure 118: MEA Attractiveness by Indication, 2022 to 2032

Figure 119: MEA Attractiveness by End User, 2022 to 2032

Figure 120: MEA Attractiveness by Country, 2022 to 2032